Sjs Investment Consulting Inc. Horizon Therapeutics Public LTD CO Transaction History

Sjs Investment Consulting Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 17, 2023	SELL	$98.98 - $115.74 $296 - $347	-3 Reduced 33.33%	6 $0
Q1 2023 Apr 20, 2023	SELL	$107.32 - $113.5 $107 - $113	-1 Reduced 10.0%	9 $0
Q4 2022 Jan 23, 2023	SELL	$62.39 - $113.8 $187 - $341	-3 Reduced 23.08%	10 $0
Q3 2022 Oct 13, 2022	BUY	$58.92 - $84.67 $589 - $846	10 Added 333.33%	13 $0
Q1 2022 May 05, 2022	BUY	$86.42 - $109.81 $259 - $329	3 New	3 $0

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Sjs Investment Consulting Inc., based on Form 13F filings with the SEC.

Stay updated on Sjs Investment Consulting Inc. with notifications on news.